Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

(2012) J. P. Leonard et al.   BLOOD

Off-Target Function of the Sonic Hedgehog Inhibitor Cyclopamine in Mediating Apoptosis via Nitric Oxide-Dependent Neutral Sphingomyelinase 2/Ceramide Induction

(2012) M. Meyers-Needham et al.   MOLECULAR CANCER THERAPEUTICS

The clinical implications of medulloblastoma subgroups

(2012) Paul A. Northcott et al.   Nature Reviews Neurology

Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model

(2012) M. J. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Molecular subgroups of medulloblastoma: the current consensus

(2011) Michael D. Taylor et al.   ACTA NEUROPATHOLOGICA

Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)

(2011) G K Schwartz et al.   BRITISH JOURNAL OF CANCER

Cdk6-Dependent Regulation of G1 Length Controls Adult Neurogenesis

(2011) Pierre Beukelaers et al.   STEM CELLS

Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts

(2010) K. Michaud et al.   CANCER RESEARCH

miR-129 regulates cell proliferation by downregulating Cdk6 expression

(2010) Junjie Wu et al.   CELL CYCLE

Medulloblastoma Comprises Four Distinct Molecular Variants

(2010) Paul A. Northcott et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNA 128a Increases Intracellular ROS Level by Targeting Bmi-1 and Inhibits Medulloblastoma Cancer Cell Growth by Promoting Senescence

(2010) Sujatha Venkataraman et al.   PLoS One

Unique Molecular Characteristics of Pediatric Myxopapillary Ependymoma

(2009) Valerie N. Barton et al.   BRAIN PATHOLOGY

The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials

(2009) Barry L. Pizer et al.   BRITISH JOURNAL OF NEUROSURGERY

Medulloblastoma

(2009) Girish Dhall   JOURNAL OF CHILD NEUROLOGY

Cell cycle kinases as therapeutic targets for cancer

(2009) Silvia Lapenna et al.   NATURE REVIEWS DRUG DISCOVERY

A Novel Therapeutic Combination Using PD 0332991 and Bortezomib: Study in the 5T33MM Myeloma Model

(2008) E. Menu et al.   CANCER RESEARCH

Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma

(2008) Jessica Pierson et al.   JOURNAL OF NEURO-ONCOLOGY